A practical reference on triple agonist: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-10-16 and is reviewed periodically as new material appears.
多肽类化合物的表征通常依赖色谱与质谱联用技术。反相高效液相色谱用于评估纯度与有关物质，质谱用于确认分子量，肽图分析通过酶解碎片比对验证一级结构。这些手段组合使用，可以把目标产物与降解产物或类似物区分开来。单一方法往往不足以完成完整确认。
稳定性研究一般关注脱酰胺、氧化与聚集三类降解路径。脱酰胺多发生在天冬酰胺残基上，氧化常涉及甲硫氨酸与色氨酸，聚集则与浓度、温度以及容器界面接触有关。强制降解实验用于识别分子中较敏感的位点。这些结果会直接影响储存条件的设定与有效期的判断。
冻干粉通常在低温环境下保存，复溶之后需要按指定条件在较短时间内使用。反复冻融和剧烈振荡可能促进聚集，低吸附容器则能减少多肽在管壁上的损失。批号、日期与处理条件的完整记录，是后续复核与问题追溯的基础。
Retatrutide is an investigational peptide studied for obesity and type 2 diabetes. It is a single synthetic molecule designed to activate three metabolic receptors simultaneously. The compound belongs to the incretin mimetic family, a group of peptides that imitate gut hormones involved in appetite and glucose control. Its research code is LY3437943, and it remains under clinical study rather than cleared for routine medical use.
Acting as a triple agonist, the molecule binds the GLP-1, GIP, and glucagon receptors. GLP-1 activity slows gastric emptying and dampens appetite, while GIP signaling contributes to insulin sensitivity and fat metabolism. Glucagon receptor engagement raises energy expenditure and encourages fat breakdown, although it can also elevate blood glucose. Combining three pathways is intended to yield larger weight reduction than single or dual agonists, and researchers continue to examine how the balance among them shapes tolerability.
Clinical studies have reported notable reductions in body weight among participants. Early trials measured safety and explored several dose levels, and later studies tracked body-weight change over months of treatment. Investigators also monitor effects on glycemic markers, liver fat, and blood lipids. Because the compound is still in development, questions about long-term safety, cardiovascular outcomes, and durability after treatment ends remain open.
| Property | Value | Notes |
|---|---|---|
| 长期储存温度 | 约 -20°C 或更低 | 冻干粉常见保存条件 |
| 复溶溶剂 | 注射用水或指定缓冲液 | 按方案或说明书执行 |
| 容器材质 | 低吸附聚丙烯 | 减少多肽在管壁的吸附损失 |
| 主要降解路径 | 脱酰胺、氧化、聚集 | 由序列与工艺条件共同决定 |
| 追溯材料 | 分析证书与批次记录 | 用于来源与纯度核实 |
Retatrutide is an investigational synthetic peptide that acts on three receptor targets at once: glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon. It is developed by Eli Lilly and appears in the literature and in trial registries under the code LY3437943. The molecule belongs to a class of engineered peptides designed to resist rapid breakdown and permit infrequent subcutaneous administration. No regulatory agency has approved it for clinical use, and all available human data come from controlled trials rather than from routine practice.
The intended pharmacology combines three signals in one molecule. GLP-1 receptor activation reduces appetite and slows gastric emptying, effects already exploited by approved incretin-based therapies. GIP receptor engagement is associated with improved insulin sensitivity and with direct effects on adipose tissue, although how much it contributes to overall outcomes is still debated. Glucagon receptor agonism raises energy expenditure and supports hepatic lipid handling, a mechanism that also tends to increase glucose output. The triple profile is hypothesized to produce a larger metabolic effect than single or dual agonism, but the relative weight of each receptor in humans is not settled.
Retatrutide is an investigational synthetic peptide that acts as an agonist at three distinct G protein-coupled receptors. It combines activity at the glucagon-like peptide-1 receptor, the glucose-dependent insulinotropic polypeptide receptor, and the glucagon receptor within a single molecule. This multi-receptor profile distinguishes it from earlier incretin-based compounds that engage one or two of these pathways. Researchers designed the molecule to test whether simultaneous activation produces greater metabolic effects than single or dual agonism alone.
The peptide backbone is chemically modified to resist rapid enzymatic breakdown in the body. A fatty acid side chain promotes binding to serum albumin, which slows renal clearance and supports an extended circulation time. These modifications allow less frequent administration than would be possible with an unmodified peptide. The precise contribution of glucagon receptor activation to the overall metabolic effect remains an area of active investigation, because glucagon raises glucose while also increasing energy expenditure.
== Gene == There are an estimated 30 people in the world that have been diagnosed with the congenital form of Factor II deficiency, which should not be confused with the prothrombin G20210A mutation, which is also called the factor II mutation. Prothrombin G20210A is congenital. Prothrombin G20210A is not usually accompanied by other factor mutations (i.e., the most common is factor V Leiden). The gene may be inherited heterozygous (1 pair), or much more rarely, homozygous (2 pairs), and is not related to gender or blood type. Homozygous mutations increase the risk of thrombosis more than heterozygous mutations, but the relative increased risk is not well documented. Other potential risks for thrombosis, such as oral contraceptives may be additive. The previously reported relationship of inflammatory bowel disease (i.e., Crohn's disease or ulcerative colitis) and prothrombin G20210A or factor V Leiden mutation have been contradicted by research.
{\displaystyle {\begin{aligned}\rho \left({\frac {\partial u_{x}}{\partial t}}+u_{x}{\frac {\partial u_{x}}{\partial x}}+u_{y}{\frac {\partial u_{x}}{\partial y}}\right)&=-{\frac {\partial p}{\partial x}}+\mu \left({\frac {\partial ^{2}u_{x}}{\partial x^{2}}}+{\frac {\partial ^{2}u_{x}}{\partial y^{2}}}\right)+\rho g_{x}\\\rho \left({\frac {\partial u_{y}}{\partial t}}+u_{x}{\frac {\partial u_{y}}{\partial x}}+u_{y}{\frac {\partial u_{y}}{\partial y}}\right)&=-{\frac {\partial p}{\partial y}}+\mu \left({\frac {\partial ^{2}u_{y}}{\partial x^{2}}}+{\frac {\partial ^{2}u_{y}}{\partial y^{2}}}\right)+\rho g_{y}.\end{aligned}}}
On 7 December 2024, Syrian rebels announced that they had started surrounding Damascus after capturing nearby towns, with rebel commander Hassan Abdul Ghani stating: "Our forces have begun implementing the final phase of encircling the capital Damascus." The rebels started encircling the capital after capturing Al-Sanamayn, a town 20 kilometres (12 mi) from the southern entrance of Damascus. In the Rif Dimashq region, pro-government forces withdrew from the towns of Assal al-Ward, Yabroud, Flitah, Al-Naseriyah and Artouz, while rebels came within 10 kilometres (6.2 mi) of Damascus. The Syrian government denied claims that its army had withdrawn from positions near the city. By the evening, pro-government forces had left the towns on the outskirts of Damascus, including Jaramana, Qatana, Muadamiyat al-Sham, Darayya, Al-Kiswah, Al-Dumayr, Daraa and sites near the Mezzeh Air Base. Maher al-Assad and his 4th Division were reportedly among the few loyalists who still tried to defend the city; his second-in-command was later found dead in his office, possibly indicating violent disputes over the orders and escapes of many military officers. According to the Syrian Observatory for Human Rights, Syrian rebels were active in the Damascus suburbs of Jaramana, Muadamiyah, and Darayya, and were marching from the east toward Harasta. In the main square of Jaramana, protestors took down a statue of Hafez al-Assad. In the evening, pro-government forces reportedly withdrew from several suburbs where large-scale protests broke out.
Sources: en.wikipedia.org
Bats provide humans with some direct benefits, at the cost of some disadvantages. Bat dung has been mined as guano from caves and used as fertiliser. Bats consume insect pests, reducing the need for pesticides and other insect management measures. Bats are sometimes numerous enough and close enough to human settlements to serve as tourist attractions, and they are used as food in Africa, Asia, the Pacific and the Caribbean. Due to their physiology, bats are one type of animal that acts as a natural reservoir of many pathogens, such as rabies, and since they are highly mobile, social, and long-lived, they can readily spread disease among themselves. If humans interact with bats, these traits become potentially dangerous to humans. Depending on the culture, bats may be symbolically associated with positive traits, such as protection from certain diseases or risks, rebirth, or long life, but in the West, bats are popularly associated with darkness, malevolence, witchcraft, and vampires.
Vaginal discharge may indicate a vaginal infection by color and odor, or the resulting symptoms of discharge, such as irritation or burning. Abnormal vaginal discharge may be caused by STIs, diabetes, douches, fragranced soaps, bubble baths, birth control pills, yeast infection (commonly as a result of antibiotic use) or another form of vaginitis. While vaginitis is an inflammation of the vagina, and is attributed to infection, hormonal issues, or irritants, vaginismus is an involuntary tightening of the vagina muscles during vaginal penetration that is caused by a conditioned reflex or disease. Vaginal discharge due to yeast infection is usually thick, creamy in color and odorless, while discharge due to bacterial vaginosis is gray-white in color, and discharge due to trichomoniasis is usually a gray color, thin in consistency, and has a fishy odor. Discharge in 25% of the trichomoniasis cases is yellow-green. HIV/AIDS, human papillomavirus (HPV), genital herpes and trichomoniasis are some STIs that may affect the vagina, and health sources recommend safe sex (or barrier method) practices to prevent the transmission of these and other STIs. Safe sex commonly involves the use of condoms, and sometimes female condoms (which give women more control). Both types can help avert pregnancy by preventing semen from coming in contact with the vagina.
If the protactinium remains in the reactor, small amounts of uranium-232 are also produced, which has the strong gamma emitter thallium-208 in its decay chain. Similar to uranium-fueled designs, the longer the fuel and fertile material remain in the reactor, the more of these undesirable elements build up. In the envisioned commercial thorium reactors, high levels of uranium-232 would be allowed to accumulate, leading to extremely high gamma-radiation doses from any uranium derived from thorium. These gamma rays complicate the safe handling of a weapon and the design of its electronics; this explains why uranium-233 has never been pursued for weapons beyond proof-of-concept demonstrations. While the thorium cycle may be proliferation-resistant with regard to uranium-233 extraction from fuel (because of the presence of uranium-232), it poses a proliferation risk from an alternate route of uranium-233 extraction, which involves chemically extracting protactinium-233 and allowing it to decay to pure uranium-233 outside of the reactor. This process is an obvious chemical operation which is not required for normal operation of these reactor designs, but it could feasibly happen beyond the oversight of organizations such as the International Atomic Energy Agency (IAEA), and thus must be safeguarded against.
Sources: en.wikipedia.org
Le Cerveau by Gérard Oury (1968) La Beuze (2003) Disco (2008) La Fée, also presented at the Directors' Fortnight in 2011. The film by Sophie Marceau, La Disparue de Deauville, made in 2007, contains many scenes around the port of Le Havre, in the Coty shopping centre of Coty and in the streets of the central city. The film Le Havre by Aki Kaurismäki received two prizes at the 2011 Cannes Film Festival and also the Louis Delluc Prize. It was nominated three times for the 37th César Awards.
De emerges, in retrospect, as a modest self-effacing scientist driven by inner compulsions to grapple with a major scientific problem of the time. His choice of cholera as his field of interest was remarkably appropriate to his setting. To this problem De brought a wonderfully thoughtful approach, together with deep intuition, enabling him to make the long-awaited breakthrough in the field."
Myeloproliferative disease (primarily essential thrombocythemia and polycythemia vera). It has been found to be superior to anagrelide for the control of ET. Sickle-cell disease (increases production of fetal hemoglobin that then interferes with the hemoglobin polymerisation as well as by reducing white blood cells that contribute to the general inflammatory state in sickle cell patients.) Second line treatment for psoriasis (slows down the rapid division of skin cells) Systemic mastocytosis with associated hematological neoplasm(SM-AHN) (The utility in treating SM-AHN with hydroxycarbamide stems from its myelosuppressive activity, it does not however exhibit any selective anti-mast cell activity) Chronic myelogenous leukemia (largely replaced by imatinib, but still in use for its cost-effectiveness)
Sources: en.wikipedia.org
常用质谱测定分子量，再结合肽图或序列分析验证一级结构。单一检测手段一般难以排除结构相近的类似物。多种方法相互印证更为可靠。
低温可以降低水解与聚集的速率，从而延缓降解进程。温度反复波动本身也可能造成相变与样品损失。稳定的储存条件是可重复结果的前提。
分析证书、批次编号、所用检测方法与结果，以及标称储存条件。缺少方法细节的报告难以独立复核。记录完整性决定了追溯能否成立。
It is a synthetic peptide classified as a triple receptor agonist. It engages the GLP-1, GIP, and glucagon receptors at once. It is investigated for metabolic and weight-related conditions rather than approved for general use.